In short. No early volume, a slower build and a different lump profile. How this class behaves next to the others, without re-explaining how collagen stimulation works.
Key points
- Would I rather see something immediately, or have the change accumulate without my watching it?
- A patient who wants evidence in the first fortnight is better served by a class with carrier volume or by a reversible filler.
- A patient who finds the immediate change reassuring rather than clarifying has learned something about which treatment to choose.
The stimulator classes are often discussed as variations on one treatment with different durations. They behave differently in the first month, ask different things of the patient, and carry risks that are not identical. Three differences define this one.
Nothing is visible at the start
Other classes place material suspended in a carrier that gives volume on the day, so the area looks fuller immediately and the patient has something to look at while the gradual effect develops. This substance does not. The appointment ends with no visible change, and the treated area may look exactly as it did before for several weeks. That is the defining feature of a course, and it shapes everything else: how the patient experiences the first month, how the review is timed, and why the flat period is the point at which courses are abandoned.
The build is slower and is judged later
The first change usually appears between two and three months and continues between sessions rather than after each one. It keeps building after the final injection, which is why the total effect exceeds what was visible at any visit and why the honest point of judgement is between six and twelve months. The slow build is not a virtue and not a defect; it is the reason the treatment is well tolerated by the tissue and the reason it is unsuitable for anyone who needs a result by a date.
The question that sorts the classes
Would I rather see something immediately, or have the change accumulate without my watching it? A patient who wants evidence in the first fortnight is better served by a class with carrier volume or by a reversible filler. A patient who finds the immediate change reassuring rather than clarifying has learned something about which treatment to choose.
The lump profile is different
Firmness in the first weeks occurs with every stimulator. With this substance the finding that matters tends to appear later, in the months when the result is being judged, and it is linked to how deeply and how evenly the material was placed. Preparation and plane matter more than the product name, and the spacing of sessions matters more than either. That is worth understanding before comparing classes, because it moves the decision away from the substance and towards the person injecting it.
Where the comparison misleads
- Choosing this class for a result you need to see before a particular date.
- Assuming a longer and slower build is automatically better, when it is only better if the result is wanted.
- Comparing classes on how strong they sound rather than on what happens if the result is uneven.
The practical consequence is that this substance is chosen by a patient who is content to wait without evidence, wants a diffuse change rather than a defined one, and has accepted that nothing about the result can be reversed. Where any of those three is missing, another class or another treatment is the better answer, and an assessment should say so rather than adjust the expectation.
Frequently asked questions
Why is there nothing to see on the day with this substance?
Because it is not carried in a gel that gives volume, so the appointment ends with no visible change and the following week often looks the same. Other stimulator classes put something visible in the area immediately. Here the effect is entirely the collagen that develops later.
Is a slower build a disadvantage?
It is a disadvantage for a patient who needs a result soon, and it is what makes the treatment tolerable for the tissue, because the change accumulates gradually rather than arriving at once. The trade is real in both directions and worth stating plainly rather than presenting as a virtue.
Does the lump risk differ between the classes?
The risk exists in all of them and the profile differs. With this substance the firmness that appears is typically related to how deeply and how evenly the material is placed, and it tends to show in the months when the result is being judged rather than in the first fortnight.
Risks & Limitations
- Irreversibility: there is no agent that reverses this substance. An uneven or unwanted result is managed over time, with injected treatment, or occasionally by removal, and never switched off.
- Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment, most often in the window when the result is being judged.
- Unevenness or over-correction, which is harder to correct than under-treatment in an area that cannot be dissolved.
- Nothing is visible on the day and the treated area may look unchanged for several weeks. This is expected rather than a sign the treatment has failed.
- Infection or inflammation at an injection site, which needs prompt assessment rather than waiting.
- Tenderness, swelling, occasional bruising and occasional headache after treatment.
- The result develops over months, cannot be judged before six months, is not permanent, and declines gradually after its fullest point; the face continues to age.
When to Seek Care
- A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
- Redness, warmth, swelling or pus at an injection site, or fever.
- Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
- Increasing pain, or pain out of proportion to the injection.
- Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable and skin safety information
- American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
- U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
- National Medical Products Administration (NMPA, China) — approved product status
- Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.